METHYLNALTREXONE AND RIFAXIMIN TREATMENTS SIGNIFICANTLY IMPROVE CHRONIC “LEAKY GUT” IN A DIET-INDUCED MOUSE MODEL OF NONALCOHOLIC FATTY LIVER DISEASE

Rebecca Caffrey ¹ William Jo ² Nicole Deng ³ Madhavi Bhat ³ Jonathon Marioneaux ³
¹ Sanyal Biotechnology LLC, Norfolk, United States
² Bausch Health Companies Inc, Petaluma, United States
³ Bausch Health Companies Inc, Bridgewater, United States

Session
Liver & biliary (Posters)

Conference
UEG Week Virtual 2020

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)

Do you need help setting up your myUEG account?
Contact us at [email protected]

Social Sharing